Russell Investments Group Ltd. trimmed its stake in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 7.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 403,913 shares of the company’s stock after selling 32,213 shares during the period. Russell Investments Group Ltd. owned approximately 0.78% of The Ensign Group worth $15,311,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. BlackRock Inc. increased its position in shares of The Ensign Group by 14.1% during the second quarter. BlackRock Inc. now owns 7,187,953 shares of the company’s stock worth $257,471,000 after acquiring an additional 890,137 shares in the last quarter. Segall Bryant & Hamill LLC bought a new position in The Ensign Group in the second quarter valued at $30,968,000. WINTON GROUP Ltd bought a new position in The Ensign Group in the second quarter valued at $16,497,000. Gagnon Securities LLC bought a new position in The Ensign Group in the second quarter valued at $8,784,000. Finally, Advisors Asset Management Inc. grew its position in The Ensign Group by 14,877.2% in the second quarter. Advisors Asset Management Inc. now owns 239,336 shares of the company’s stock valued at $103,000 after purchasing an additional 237,738 shares in the last quarter. Institutional investors own 84.17% of the company’s stock.
NASDAQ:ENSG traded up $0.32 during mid-day trading on Monday, reaching $45.69. 335,000 shares of the company’s stock were exchanged, compared to its average volume of 266,731. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.41 and a current ratio of 1.41. The Ensign Group, Inc. has a one year low of $21.67 and a one year high of $48.17. The firm has a market cap of $2.37 billion, a price-to-earnings ratio of 37.47, a P/E/G ratio of 1.77 and a beta of 0.67.
In related news, Director John G. Nackel sold 1,000 shares of The Ensign Group stock in a transaction that occurred on Friday, October 5th. The shares were sold at an average price of $38.25, for a total transaction of $38,250.00. Following the sale, the director now directly owns 78,232 shares of the company’s stock, valued at approximately $2,992,374. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Chad Keetch sold 64,039 shares of The Ensign Group stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $44.90, for a total transaction of $2,875,351.10. Following the sale, the vice president now directly owns 70,892 shares in the company, valued at $3,183,050.80. The disclosure for this sale can be found here. Over the last three months, insiders sold 98,933 shares of company stock worth $4,301,915. Insiders own 6.00% of the company’s stock.
ENSG has been the subject of a number of recent analyst reports. Stephens reiterated a “buy” rating and issued a $41.00 price target on shares of The Ensign Group in a research note on Sunday, August 5th. Zacks Investment Research cut shares of The Ensign Group from a “buy” rating to a “hold” rating in a research note on Wednesday, August 22nd. BidaskClub cut shares of The Ensign Group from a “buy” rating to a “hold” rating in a research note on Friday, September 14th. Stifel Nicolaus set a $34.00 target price on shares of The Ensign Group and gave the stock a “hold” rating in a research note on Thursday, August 16th. Finally, Cantor Fitzgerald raised their target price on shares of The Ensign Group from $42.00 to $50.00 and gave the stock an “overweight” rating in a research note on Friday, November 2nd. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $40.71.
The Ensign Group Profile
The Ensign Group, Inc provides health care services in the post-acute care continuum and other ancillary businesses in the United States. It operates through three segments: Transitional and Skilled Services; Assisted and Independent Living Services; and Home Health and Hospice Services. The Transitional and Skilled Services segment offers a range of medical, nursing, rehabilitative, and pharmacy services, as well as routine services, including daily dietary, social, and recreational services to Medicaid, private pay, managed care, and Medicare payors.
See Also: Price to Earnings Ratio (PE)
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.